Skip to the main content.

1 min read

Continued Process Verification

Continued Process Verification (Stage 3)

The goal of Continued Process Verification (CPV) is to ensure that the process remains in a state of control during commercial manufacture. It involves setting up and maintaining a system for detecting and investigating deviation from expected trends. The program at KBI involves process and product quality data collection, statistical analysis of data to identify undesirable process variation, process performance reviews, a risk-based approach in initiating and investigating for identifying the root cause of an undesirable process variation and implementing a corrective action if required.

There are 2 CPV phases. An initial phase is used to gain enough process experience to establish statistical control limits. During this phase, initial limits are used and are typically based on prior process experience and data from the development phase. The next phase is referred to as the steady-state or the long-term monitoring phase. The control limits during this phase are established based on a longer term performance of the process. These control limits are based more on statistics. In general, statistical control limits are set at the centerline plus and minus three sigma, which approximates to three standard deviations. As a rule of thumb, steady-state limits are typical based about 20-30 data points for each parameter. These limits are not changed without recorded justification.

A CPV plan initiated for each commercial process at KBI. It is considered a living document and is updated as process changes are made or when there is a confirmed shift in process performance (raw material change, etc.).

1 min read

Biosimilar Development

Biosimilars - Biobetters - Biosuperiors: Biosimilar development offers a truly unique set of challenges. Success requires thoughtful, rational...

Read More

1 min read

Process Characterization - Process Definition, Design, and Control Strategy

Process Design: Process Definition, Characterization and Control Strategy (Stages 1a and 1b) Scale-down process characterization studies performed...

Read More
Using Advanced Mass Spectrometry for Characterization and Quantitation of APIs and Impurities in Complex Biotherapeutics

5 min read

Using Advanced Mass Spectrometry for Characterization and Quantitation of APIs and Impurities in Complex Biotherapeutics

Increasing global demand for vaccines and complex biotherapeutics has led to a larger role for Contract Development and Manufacturing Organizations...

Read More